Latest News
Airline company United Airlines Holdings (NASDAQ:UAL) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 5.4% year on year to $13.21 billion. Its non-GAAP profit of $0.91 per share was 23.8% above analysts’ consensus estimates.
Via StockStory · April 15, 2025
There are reports that the streaming pioneer has plans to reach some lofty goals.
Via The Motley Fool · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 15, 2025
The headline reading came in better than expected, rising from a 15-month low of -20 last month to -8.1 in April.
Via Talk Markets · April 15, 2025
Via The Motley Fool · April 15, 2025
Via Benzinga · April 15, 2025
Apple (NASDAQ:AAPL): iPhone and iPad maker Apple (NASDAQ:AAPL) rose by 6.5% on Monday after reports indicated that smartphones, computers, and a wide range of tech devices and components would be exempt from the reciprocal tariffs on U.S. imports announced on April 2, 2025. See our full article here.
Via StockStory · April 15, 2025
The USD Index's recent decline has been driven more by sentiment than fundamentals, creating a situation where, just like in 2018, the market appears to have priced in the worst-case scenario.
Via Talk Markets · April 15, 2025
United Airlines reports first-quarter revenue of $13.21 billion, missing analyst estimates of $13.25 billion.
Via Benzinga · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 15, 2025
BofA Securities analyst maintains Buy rating on Netflix with $1,175 target. Predicts continued positive subscriber and earnings growth, potential in advertising and live opportunities, and a $1 trillion valuation by 2030. Shares expected to react positively.
Via Benzinga · April 15, 2025
The bank had an excellent quarter, despite a challenging environment.
Via Talk Markets · April 15, 2025
Interactive Brokers releases its first-quarter results after Tuesday's closing bell. Here's a look at the key figures from the report.
Via Benzinga · April 15, 2025
FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown contents and unverified sterility.
Via Benzinga · April 15, 2025